Winfield Associates’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.71M | Sell |
20,778
-3,312
| -14% | -$431K | 0.98% | 27 |
|
|
2021
Q4 | $3.68M | Sell |
24,090
-950
| -4% | -$147K | 1.22% | 19 |
|
|
2021
Q3 | $4.05M | Sell |
25,040
-310
| -1% | -$52.2K | 1.5% | 13 |
|
|
2021
Q2 | $4.15M | Sell |
25,350
-862
| -3% | -$133K | 1.53% | 13 |
|
|
2021
Q1 | $3.95M | Buy |
26,212
+897
| +4% | +$142K | 1.61% | 13 |
|
|
2020
Q4 | $3.83M | Buy |
25,315
+147
| +0.6% | +$21K | 1.62% | 12 |
|
|
2020
Q3 | $3.41M | Buy |
25,168
+1,416
| +6% | +$192K | 1.62% | 13 |
|
|
2020
Q2 | $3.25M | Buy |
23,752
+9,165
| +63% | +$1.17M | 1.66% | 12 |
|
|
2020
Q1 | $1.57M | Buy |
14,587
+220
| +2% | +$25.3K | 0.99% | 30 |
|
|
2019
Q4 | $1.73M | Sell |
14,367
-1,710
| -11% | -$191K | 0.8% | 34 |
|
|
2019
Q3 | $1.6M | Sell |
16,077
-5,415
| -25% | -$567K | 0.78% | 36 |
|
|
2019
Q2 | $2.35M | Sell |
21,492
-2,700
| -11% | -$287K | 1.22% | 24 |
|
|
2019
Q1 | $2.71M | Sell |
24,192
-1,975
| -8% | -$217K | 1.44% | 19 |
|
|
2018
Q4 | $2.52M | Sell |
26,167
-3,073
| -11% | -$326K | 1.54% | 17 |
|
|
2018
Q3 | $3.57M | Sell |
29,240
-602
| -2% | -$70.9K | 1.76% | 14 |
|
|
2018
Q2 | $3.28M | Sell |
29,842
-4,765
| -14% | -$510K | 1.76% | 16 |
|
|
2018
Q1 | $3.69M | Sell |
34,607
-525
| -1% | -$58.2K | 1.99% | 15 |
|
|
2017
Q4 | $3.75M | Sell |
35,132
-8,605
| -20% | -$920K | 1.9% | 13 |
|
|
2017
Q3 | $4.86M | Sell |
43,737
-1,470
| -3% | -$157K | 2.56% | 8 |
|
|
2017
Q2 | $4.67M | Sell |
45,207
-1,275
| -3% | -$126K | 2.58% | 7 |
|
|
2017
Q1 | $4.54M | Sell |
46,482
-8,055
| -15% | -$771K | 2.58% | 7 |
|
|
2016
Q4 | $4.82M | Sell |
54,537
-5,505
| -9% | -$501K | 2.96% | 5 |
|
|
2016
Q3 | $5.79M | Sell |
60,042
-1,386
| -2% | -$132K | 3.64% | 3 |
|
|
2016
Q2 | $5.27M | Sell |
61,428
-4,350
| -7% | -$390K | 3.44% | 4 |
|
|
2016
Q1 | $5.72M | Sell |
65,778
-11,400
| -15% | -$1.02M | 3.88% | 5 |
|
|
2015
Q4 | $8.7M | Sell |
77,178
-900
| -1% | -$97.7K | 5.83% | 1 |
|
|
2015
Q3 | $7.89M | Buy |
78,078
+2,088
| +3% | +$250K | 5.9% | 1 |
|
|
2015
Q2 | $9.35M | Sell |
75,990
-45
| -0.1% | -$5.39K | 6.4% | 1 |
|
|
2015
Q1 | $8.7M | Sell |
76,035
-2,115
| -3% | -$233K | 6.1% | 1 |
|
|
2014
Q4 | $7.9M | Sell |
78,150
-369
| -0.5% | -$35.9K | 5.81% | 1 |
|
|
2014
Q3 | $7.16M | Buy |
78,519
+2,400
| +3% | +$211K | 5.33% | 1 |
|
|
2014
Q2 | $6.52M | Sell |
76,119
-7,476
| -9% | -$589K | 4.73% | 1 |
|
|
2014
Q1 | $6.59M | Buy |
83,595
+2,565
| +3% | +$214K | 5.44% | 1 |
|
|
2013
Q4 | $6.13M | Buy |
+81,030
| New | +$5.75M | 5.04% | 1 |
|
Other funds holding IBB
Winfield Associates's IBB Position: Q1 2022 in Review
Winfield Associates reduced its iShares Biotechnology ETF (IBB) stake by 14% in Q1 2022, selling an estimated $431K and leaving 20,778 shares worth $2.71M. The position accounts for 0.98% of the portfolio, ranked #27.
Winfield Associates first reported a position in IBB in Q4 2013 and has held it in 34 quarters since. The position peaked at $9.35M in Q2 2015. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.
- Winfield Associates held 20,778 shares of iShares Biotechnology ETF worth $2.71M as of Q1 2022.
- Winfield Associates sold 3,312 iShares Biotechnology ETF shares in Q1 2022, an estimated $431K.
- iShares Biotechnology ETF made up 0.98% of Winfield Associates's portfolio in Q1 2022, its #27 holding.
- Winfield Associates first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 34 quarters since.
- Winfield Associates's iShares Biotechnology ETF position peaked at $9.35M in Q2 2015.
- 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.
Based on Winfield Associates's 13F filing for Q1 2022, filed 5 Apr 2022.